公司資料
Charles River 股價、新聞與催化劑
- 股票代碼:
- CRL
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
286.64 USD (+2.35%)
收盤價
最後更新: 2026年8月17日
8.42B USD
市值
股價為何變動
As of Aug 17, 2026, CRL closed up 2.35% at $286.64. No new same-company headline was identified in the current news window.
公司概覽
Preclinical Research Services
Charles River Laboratories provides products and outsourced services used by pharmaceutical, biotechnology, academic and government researchers across early drug development.
Research Models and Services
The company supplies research models and related services used in basic research, target validation and preclinical studies. It also provides safety-assessment and discovery services.
Manufacturing Solutions
Charles River supports biologic testing, microbial solutions and other quality-control activities used in pharmaceutical manufacturing. Following divestitures, the company is refocusing on its core research and preclinical portfolio.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。